You are here

  • Home
  • Archive
  • Volume 81, Issue Suppl 1
  • AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice

Article metrics

Article menu

Download PDFPDF

Scientific Abstracts
Publication Only
Scleroderma, myositis and related syndromes
AB0728 Comparative results of long-term (for 36 months) use of rituximab and immunosuppressants in patients with systemic scleroderma with interstitial lung disease in real clinical practice
Free

 

Online download statistics by month:

Online download statistics by month: May 2022 to November 2024

AbstractFullPdf
May 2022400
Jun 20222108
Jul 20222104
Aug 20223507
Sep 20222302
Oct 20221201
Nov 20222206
Dec 20223503
Jan 20233002
Feb 20231206
Mar 2023401
Apr 2023201
Jun 2023502
Jul 2023605
Aug 2023800
Sep 20231905
Oct 2023500
Nov 20231202
Dec 20231401
Jan 20245200
Feb 20249605
Mar 20242005
Apr 202434010
May 20242000
Jun 20243404
Jul 2024604
Aug 20241402
Sep 20241901
Oct 20241507
Nov 20242006
Total6200100